Page last updated: 2024-12-06

zetidoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

zetidoline: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72155
CHEMBL ID2105481
SCHEMBL ID2111327
MeSH IDM0088805

Synonyms (26)

Synonym
zetidoline
dl-308 ,
mdl 308
1-(2-(3,3-dimethylazetidin-1-yl)ethyl)-3-(3-chlorophenyl)-2-imidazolidinone
zetidolinum [inn-latin]
1-(m-chlorophenyl)-3-(2-(3,3-dimethyl-1-azetidinyl)ethyl)-2-imidazolidinone
2-imidazolidinone, 1-(3-chlorophenyl)-3-(2-(3,3-dimethyl-1-azetidinyl)ethyl)-
zetidolina [inn-spanish]
1-(3-chlorophenyl)-3-(2-(3,3-dimethyl-1-azetidinyl)ethyl)-2-imidazolidinone
brn 0677045
1-(3-chlorophenyl)-3-[2-(3,3-dimethylazetidin-1-yl)ethyl]imidazolidin-2-one
51940-78-4
CHEMBL2105481
zetidolinum
zetidolina
zetidoline [inn:ban]
3b5j9tg94x ,
unii-3b5j9tg94x
zetidoline [inn]
1-(m-chlorophenyl)-3-[2-(3,3-dimethylazetidin-1yl)-ethyl]-2-imidazolidinone
AHDBQMJRRXVRDY-UHFFFAOYSA-N
SCHEMBL2111327
DTXSID70199910
4-(4-bromophenoxy)benzoicacid97
Q27256994
AKOS040754568

Research Excerpts

Effects

ExcerptReferenceRelevance
"[3H]Zetidoline has high affinity for striatal dopamine receptors."( Characterization of [3H]zetidoline binding to rat striatal membranes.
Assandri, A; Barone, D; Galliani, G; Glässer, A; Tarzia, G, 1985
)
1.06

Dosage Studied

ExcerptRelevanceReference
" In the 6th and 8th h after the 10-mg dosage but also after the 40-mg dose some activating properties were observed, as indicated by the decrease in slow waves and increase in slow beta activity and average frequency."( Determination of pharmacodynamics of the new neuroleptic zetidoline by neuroendocrinologic, pharmaco-EEG, and psychometric studies--Part I.
Dubini, A; Grünberger, J; Linzmayer, L; Saletu, B, 1983
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-199028 (93.33)18.7374
1990's2 (6.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials8 (25.81%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (74.19%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]